Benitec Biopharma (BNTC) Cost of Revenue (2019 - 2024)
Historic Cost of Revenue for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2024 value amounting to $3000.0.
- Benitec Biopharma's Cost of Revenue changed N/A to $3000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $3000.0, marking a year-over-year decrease of 9719.63%. This contributed to the annual value of $108000.0 for FY2024, which is N/A changed from last year.
- Latest data reveals that Benitec Biopharma reported Cost of Revenue of $3000.0 as of Q1 2024.
- Over the past 5 years, Benitec Biopharma's Cost of Revenue peaked at $134000.0 during Q3 2020, and registered a low of -$48000.0 during Q2 2020.
- Its 5-year average for Cost of Revenue is $27900.0, with a median of $8000.0 in 2021.
- Its Cost of Revenue has fluctuated over the past 5 years, first tumbled by 9379.08% in 2020, then skyrocketed by 80000.0% in 2022.
- Quarter analysis of 5 years shows Benitec Biopharma's Cost of Revenue stood at $19000.0 in 2020, then tumbled by 94.74% to $1000.0 in 2021, then soared by 800.0% to $9000.0 in 2022, then plummeted by 88.89% to $1000.0 in 2023, then surged by 200.0% to $3000.0 in 2024.
- Its last three reported values are $3000.0 in Q1 2024, $1000.0 for Q4 2023, and $106000.0 during Q3 2023.